#microbiology diagnostic devices and equipment market growth

[global-research-report]

Trends in the Laboratory Centrifuges Market

The global laboratory centrifuges market size was estimated at USD 1.73 billion in 2023 and is projected to grow at a CAGR of 5.70% from 2024 to 2030 due to advancements in application and increased research activities. Laboratory centrifuge is essential in separating mixtures based on density, making them crucial in various fields such as biotechnology, pharmaceuticals, and clinical diagnostics.

The increasing demand for personalized medicine and advancements in genomics and proteomics is anticipated to fuel the demand for centrifuge equipment. Moreover, the rise in the prevalence of chronic diseases, growing diagnostic testing, and increasing developments of advanced products are anticipated to propel the market growth in the coming years. For instance, in February 2022, Beckman Coulter Life Sciences introduced the Allegra V-15R Benchtop Centrifuge. This new model has ten rotor configurations and 50 programmable runs, complemented by a wide range of adapters. Its versatile design enables a variety of workflows and model types, including blood separation and high-throughput screening.

Furthermore, technological advancements are anticipated to influence the laboratory centrifuges market over the forecast period. Innovations such as automated and high-speed centrifuges have improved efficiency and accuracy, which are critical in laboratory settings. The development of compact and user-friendly models has also made these devices more accessible to smaller labs and research facilities. For instance, in April 2021, Eppendorf launched the Centrifuge 5910 Ri, a new model designed to boost laboratory efficiency. This centrifuge offers scientists advanced features to streamline and expedite their workflow. Its innovative touchscreen interface allows for rapid parameter settings, while three levels of user management options enhance security and traceability. Such technological advancements and novel developments are anticipated to drive the laboratory centrifuges market.

Laboratory Centrifuges Market Segment Highlights

The equipment segment held the largest share of 82.63% in 2023, driven by advancements in technology and the growing focus of key industry participants on developing novel equipment. 

The floor-standing centrifuge segment held the largest share of 54.88% in 2023, driven by advancements in technology and continuous innovation. 

The clinical centrifuge segment dominated the market with a share of 45.78% in 2023. The clinical centrifuge market is a rapidly growing sector of the healthcare industry, driven by the increasing demand for accurate and efficient diagnostic testing in hospitals, research laboratories, and clinical settings.

The microbiology segment held the largest share of 34.3% in 2023. Due to the growing need for rapid and accurate detection of microorganisms in various applications such as clinical diagnostics, pharmaceutical research, and food safety testing. 

Global Laboratory Centrifuges Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the laboratory centrifuges market report on the basis of product, intended use, application, model, and region.

Product Outlook (Revenue, USD Million, 2018 - 2030)

Equipment

Accessories

Model Outlook (Revenue, USD Million, 2018 - 2030)

Floor-Standing Centrifuges

Benchtop Centrifuges

Intended Use Outlook (Revenue, USD Million, 2018 - 2030)

Clinical Centrifuges

Preclinical Centrifuges

General Purpose Centrifuges

Application Outlook (Revenue, USD Million, 2018 - 2030)

Microbiology

Cellomics

Proteomics

Diagnostics

Genomics

Others

Regional Outlook (Revenue, USD Million, 2018 - 2030)

North America

US

Canada

Mexico

Europe

UK

Germany

France

Italy

Spain

Norway

Denmark

Sweden

Asia Pacific

Japan

China

India

Australia

South Korea

Thailand

Latin America

Argentina

Brazil

Middle East & Africa

South Africa

Saudi Arabia

UAE

Kuwait

Order a free sample PDF of the Laboratory Centrifuges Market Intelligence Study, published by Grand View Research.

[jameswilliam4u]

Global Clinical Diagnostics Market Share, Size, Trends, Outlook, Growth & Forecast | 2024 - 2032

The global clinical diagnostics market reached a value of over USD 72.23 billion in 2023, with expectations of further growth during the forecast period of 2024-2032. The market is anticipated to grow at a CAGR of around 6.7%, potentially reaching over USD 129.84 billion by 2032. This market encompasses a wide range of diagnostic tests, devices, and tools used in healthcare settings, and its expansion is driven by advancements in technology, increasing healthcare awareness, and rising demand for accurate and timely diagnostic solutions.

The clinical diagnostics sector is essential in diagnosing, monitoring, and managing diseases across different medical disciplines, such as oncology, cardiology, microbiology, and immunology. In this blog post, we will explore the key players, segments, trends, growth drivers, COVID-19 impact, and market outlook for the global clinical diagnostics market.

Get a Free Sample Report with Table of Contents: https://www.expertmarketresearch.com/reports/clinical-diagnostics-market/requestsample

Key Players in the Clinical Diagnostics Market

The global clinical diagnostics market is highly competitive, with several established players leading the space. These companies continuously innovate and expand their product portfolios to meet the growing demand for advanced diagnostic solutions. Some of the major players in the market include:

Abbott Laboratories Abbott, headquartered in Chicago, Illinois, is a global healthcare company known for its diagnostic solutions, including point-of-care testing, molecular diagnostics, and immunoassays. Abbott has been at the forefront of developing COVID-19 testing solutions and expanding its diagnostic capabilities.

Thermo Fisher Scientific Based in Waltham, Massachusetts, Thermo Fisher Scientific is a leading player in the clinical diagnostics market, providing a broad range of diagnostic equipment, reagents, and testing systems. Their offerings include molecular diagnostics, clinical chemistry, and immunoassays.

Siemens Healthineers Siemens Healthineers, a division of Siemens AG, is headquartered in Erlangen, Germany. The company provides advanced diagnostic imaging, laboratory diagnostics, and point-of-care testing solutions. Their extensive product portfolio caters to diverse diagnostic needs across multiple medical fields.

Roche Diagnostics Roche, based in Basel, Switzerland, is a major player in the clinical diagnostics market, with a comprehensive range of diagnostic tests and systems. Roche offers solutions in molecular diagnostics, immunodiagnostics, and digital diagnostics, with a strong presence in oncology and infectious diseases.

Danaher Corporation Headquartered in Washington, D.C., Danaher is a leading provider of diagnostic tools and instruments. The company has a diversified portfolio that includes molecular diagnostics, immunodiagnostics, and clinical chemistry. Danaher’s brands, such as Beckman Coulter and Cepheid, are well-recognised in the industry.

Becton, Dickinson and Company (BD) BD, based in Franklin Lakes, New Jersey, is a global medical technology company that offers diagnostic products for clinical laboratories. BD's product range includes instruments, reagents, and consumables for microbiology, immunology, and hematology diagnostics.

Bio-Rad Laboratories Headquartered in Hercules, California, Bio-Rad Laboratories is a leader in life sciences and diagnostics. The company provides products for clinical diagnostics, including immunoassays, PCR tests, and blood typing solutions.

Market Segmentation

The clinical diagnostics market can be segmented based on product type, technology, application, end-users, and geography. Understanding these segments is crucial for identifying opportunities and analysing market trends.

By Product Type:

Instruments: This segment includes diagnostic machines and devices used in clinical laboratories and point-of-care settings, such as immunoassay analyzers, PCR machines, and clinical chemistry analyzers.

Reagents and Kits: Reagents and kits used for diagnostic testing are essential components of clinical diagnostics. These include immunoassay kits, PCR kits, and molecular diagnostics reagents.

Consumables: This includes the consumables required for diagnostic tests, such as test strips, blood glucose monitoring devices, and swabs.

By Technology:

Molecular Diagnostics: Molecular diagnostic tests involve the analysis of DNA, RNA, or proteins to identify diseases. Technologies such as PCR, next-generation sequencing, and microarrays are widely used in this category.

Immunoassays: These tests rely on antigen-antibody interactions to detect the presence of specific markers or pathogens, and they are commonly used in infectious disease diagnostics.

Clinical Chemistry: Clinical chemistry involves the analysis of blood, urine, and other bodily fluids to assess organ function and diagnose conditions like diabetes, liver disease, and kidney failure.

Hematology: Hematology tests focus on blood-related disorders, such as anemia, leukemia, and coagulation disorders. These tests often involve blood cell counting and analysis.

By Application:

Infectious Disease Diagnostics: This is one of the fastest-growing segments, driven by the rising prevalence of infectious diseases, including viral, bacterial, and parasitic infections.

Oncology Diagnostics: Early detection of cancers through molecular and imaging diagnostics is becoming increasingly important in oncology care.

Cardiovascular Diagnostics: The cardiovascular segment includes tests for heart disease, such as cholesterol testing, ECG, and blood pressure monitoring.

Diabetes Diagnostics: With the growing incidence of diabetes worldwide, diagnostic tests for blood glucose and insulin levels are in high demand.

Neurological Diagnostics: Tests for neurological diseases, including Alzheimer’s, Parkinson’s, and epilepsy, are becoming more sophisticated with advancements in imaging and biomarker detection.

By End-User:

Hospitals and Clinics: The largest segment in clinical diagnostics, hospitals and clinics rely heavily on diagnostic tests for patient care, treatment planning, and disease monitoring.

Diagnostic Laboratories: These laboratories focus on offering a wide range of diagnostic tests, including blood tests, imaging, and molecular diagnostics.

Home Care Settings: With the rise in at-home diagnostic tests, especially for diabetes and cardiovascular diseases, this segment is expected to witness significant growth.

Research Institutes: Research institutions conduct diagnostic tests for clinical trials and epidemiological studies.

Market Outlook and Growth Drivers

The global clinical diagnostics market is poised for substantial growth, driven by several key factors:

Technological Advancements: Advances in molecular diagnostics, artificial intelligence, and digital health are transforming clinical diagnostics. AI-powered diagnostic tools can assist clinicians in diagnosing diseases more accurately and faster.

Increased Healthcare Spending: The growing investment in healthcare infrastructure and diagnostic technologies, particularly in emerging economies, is expanding access to diagnostic services.

Rising Prevalence of Chronic Diseases: The global rise in chronic diseases, such as diabetes, cardiovascular diseases, and cancer, is fuelling demand for diagnostic tests to monitor and manage these conditions.

Aging Population: The increasing number of elderly individuals worldwide requires more diagnostic services for managing age-related conditions and chronic diseases.

Focus on Preventive Healthcare: There is a growing emphasis on early detection and preventive healthcare, which is driving the demand for diagnostic tests.

Trends in the Clinical Diagnostics Market

Point-of-Care Diagnostics: The demand for point-of-care diagnostic tests is increasing, as they offer rapid, on-site testing, particularly in emergency situations, rural areas, and home settings.

Molecular Diagnostics Growth: Molecular diagnostics, particularly PCR-based tests, are expected to grow significantly due to their accuracy and ability to detect genetic markers of diseases.

Integration of AI in Diagnostics: Artificial intelligence is being integrated into diagnostic devices to provide more accurate and faster results. AI can assist in interpreting medical images, analysing patient data, and offering real-time diagnostics.

Telemedicine and Remote Diagnostics: The growth of telemedicine is prompting the development of remote diagnostic tools that allow healthcare professionals to diagnose patients remotely.

COVID-19 Impact on the Clinical Diagnostics Market

The COVID-19 pandemic significantly impacted the clinical diagnostics market, especially in the initial phase, with increased demand for diagnostic tests to detect the virus. COVID-19 testing, including PCR tests and rapid antigen tests, saw a surge during the peak of the pandemic.

Although the pandemic led to some disruptions in diagnostic test production and distribution, it also accelerated the adoption of diagnostic innovations, such as home testing and digital diagnostics. The demand for accurate and quick diagnostics for viral infections has led to a shift towards more advanced and automated diagnostic solutions.

Post-pandemic, the market is expected to recover and continue its growth trajectory, with a focus on developing more sophisticated diagnostic solutions for future pandemics and disease outbreaks.

Frequently Asked Questions (FAQs)

What are the main drivers of growth in the clinical diagnostics market? The main drivers include technological advancements, increasing healthcare spending, the rising prevalence of chronic diseases, and the growing focus on preventive healthcare.

Which segment is expected to grow the fastest in the clinical diagnostics market? The molecular diagnostics segment is expected to grow rapidly due to advances in PCR testing, next-generation sequencing, and biomarker identification.

How has COVID-19 affected the clinical diagnostics market? COVID-19 significantly boosted demand for diagnostic tests, especially PCR and antigen tests. It also accelerated the adoption of telemedicine and remote diagnostics, which are expected to continue post-pandemic.

Who are the leading players in the clinical diagnostics market? Key players include Abbott Laboratories, Thermo Fisher Scientific, Siemens Healthineers, Roche Diagnostics, Danaher Corporation, Becton Dickinson, and Bio-Rad Laboratories.

What is the market outlook for clinical diagnostics between 2024 and 2032? The global clinical diagnostics market is expected to grow at a CAGR of 6.7% during the forecast period, reaching a value of over USD 129.84 billion by 2032.

[bhushans]

Global Biosensors Market: A Deep Dive into Key Drivers and Trends

The global  biosensors market is anticipated to grow to a size of almost USD 65.2 billion by 2033, indicating a significant upturn in the sector. This is a substantial increase from USD 24.5 billion in 2022 and shows a robust compound annual growth rate (CAGR) of 9.5% for the projected period (2023-2033). A phase of faster market expansion is suggested by the greater projected growth rate than the preceding growth rate.

Biosensors are analytical instruments that translate biological impulses into electrical ones, allowing them to detect a wide range of compounds, including glucose and enzymes. Numerous applications in the food and beverage industry, healthcare, and environmental monitoring depend on them.

The biosensors market is being driven by an increase in biotechnology research and development, the incidence of chronic illnesses like diabetes, and the necessity for homecare equipment. The increasing use of biosensors in glucose monitoring systems is driving the market’s growth. However, it is projected that market expansion will be hampered by opposition to adopting novel treatment devices and the high cost of these equipment. However, it is expected that developments in biosensor technology that promote mobility would drive market expansion.

Refine Strategies: Request Your Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-16430

Biosensors based on nanotechnology are anticipated to yield significant profits in a range of sectors, such as food analysis, imaging, and microbiological activity monitoring. The market is getting more consolidated due to the growing need for non-invasive biosensors, customized medications, medical equipment, and more cooperation and agreements among producers in research.

Because of their ability to assess fitness as well as the onset and progression of illness, biosensors are widely used in home-based healthcare by patients. As a result, the market is expected to expand throughout the forecast period. A variety of non-medical activities, as well as technological advancement, are expected to broaden its applicability and, as a result, support its growth. Pregnancy testing, cholesterol testing, blood glucose testing, and drug detection are some of the healthcare services that are expected to have a positive market impact.

Government projects aimed at improving proteomics and genomics are expected to drive the biosensors market during the forecast period.

Competitive Analysis

Because of the increased demand for biosensors, global manufacturers are accelerating and improving their manufacturing processes by implementing cost-effective solutions. A few of the key players in the biosensors market include Bio-Rad Laboratories Inc., Medtronic, Abbott Laboratories, Biosensors International Group, Ltd., Pinnacle Technologies Inc., Ercon, Inc., DuPont Biosensor Materials, Johnson & Johnson, Koninklijke Philips N.V., LifeScan, Inc., QTL Biodetection LLC, Molecular Devices Corp., Nova Biomedical, Molex LLC, TDK Corporation, Zimmer & Peacock AS, and Siemens Healthcare.

Some of the recent developments of key Biosensors providers are as follows:

In January 2022, Roche and Sysmex agreed to a Global Business Partnership (GBP) to provide haematological diagnostic services. The new collaboration will use IT technology to improve clinical decision-making and the consumer experience. This long-running, fruitful collaboration is still going strong, providing haematological diagnostic improvements to labs worldwide.

In December 2020, Abbott announced that FreeStyle Libre 2, its next-generation sensor-based glucose monitoring device, has been approved by Health Canada for adults and children (4 years and older) with diabetes.

Market Segments Covered in Biosensors Market Analysis

By Product Type:

Medical

Cholesterol

Blood Glucose

Blood Gas Analyzer

Pregnancy Testing

Drug Discovery

Infectious Disease

Food Toxicity

Bioreactor

Agriculture

Environment

Others

By Technology:

Thermal

Electrochemical

Piezoelectric

Optical

By End-Use:

Home Healthcare Diagnostics

PoC Testing

Food Industry

Research Laboratories

Security & Biodefense

By Region:

North America

Latin America

Europe

APAC

Middle East and Africa (MEA)

[omkarpatel]

Clinical Laboratory Services Market propelled by Increasing Demand for Early Disease Diagnosis

Clinical laboratory services are crucial for diagnosis and management of various medical conditions through the analysis of specimens like blood, urine, tissues, and other body fluids. They help determine presence, absence, or extent of diseases. Clinical laboratories provide a variety of tests like sample collection and processing, chemical analysis, hematology, histopathology, immunohematology, microbiology, and serology. With the rising prevalence of chronic diseases like cancer, diabetes, and cardiovascular diseases, demand for timely diagnosis through clinical laboratory tests is growing. The global Clinical Laboratory Services Market is estimated to be valued at US$ 255.5 Bn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Opportunity: High incidence of chronic diseases offers significant growth opportunity for clinical laboratory services. As per WHO estimates, chronic diseases account for 60% of total reported deaths globally. Routine testing and monitoring plays a vital role in effective chronic disease management. The growing geriatric population which is more susceptible to chronic conditions will further drive the need for laboratory-based screening, diagnosis, and monitoring tests. This presents lucrative prospects for clinical laboratories to expand their testing portfolios and service offerings catering to chronic disease patients. Porter’s Analysis Threat of new entrants: The clinical laboratory services market requires high capital investments for setting up infrastructure and equipment. The presence of major providers and regulatory standards further increase barriers for new entrants. Bargaining power of buyers: Individual consumers have low bargaining power as they cannot bargain on price for lab tests and rely on insurance companies. However, large corporate and government buyers can negotiate on price and volume discounts. Bargaining power of suppliers: The suppliers of laboratory equipment, reagents and disposables have some bargaining power due to their specialized nature. However, the presence of alternative suppliers mitigates their influence over price setting. Threat of new substitutes: There are limited substitutes for laboratory and diagnostic services. New technology adoption is slow in this area. Competitive rivalry: The market is highly competitive with major global players dominating. Players compete based on service quality, innovation, scope of tests offered and geographical reach. SWOT Analysis Strengths: Non-invasive diagnostic procedures. Rising prevalence of chronic and infectious diseases driving demand. Weaknesses: High capital investment needs. Risk of errors and inaccurate reports. Regulatory compliance costs. Opportunities: Growing geriatric population and demand for personalized medicine and genetic testing. Adoption of LIMS and automated testing solutions. Threats: Reimbursement issues and insurance coverage problems. Competition from POC diagnostic devices. Key Takeaways The global Clinical Laboratory Services market is expected to witness high growth over the forecast period of 2023 to 2030. Regional analysis: The Asia Pacific region is projected to grow at the highest CAGR during the forecast period. This is attributed to rising healthcare spending, large patient pool, increasing penetration of insurance coverage in developing countries, growing focus of international players in emerging APAC countries.

[infinitiresearch]

Bacterial Disease Diagnostics Market| Analysis, Growth and Forecast, 2023 – 2027

Originally published on Technavio: Bacterial Disease Diagnostics Market by Product, End-user, and Geography - Forecast and Analysis 2023-2027

The Bacterial Disease Diagnostics Market is poised for substantial growth from 2023 to 2027, driven by factors such as the increasing prevalence of bacterial infections, advancements in diagnostic technologies, and a growing emphasis on early and accurate disease detection. This market's dynamics will be shaped by various factors, including different diagnostic products, end-users, and geographical trends.

In terms of diagnostic products, the Bacterial Disease Diagnostics Market encompasses a range of tools and technologies for identifying bacterial infections. These products include molecular diagnostics, immunoassays, clinical microbiology instruments, and point-of-care testing devices. Molecular diagnostics, including Polymerase Chain Reaction (PCR) and nucleic acid amplification tests, enable the specific detection of bacterial DNA or RNA, providing high sensitivity and accuracy. Immunoassays, such as enzyme-linked immunosorbent assays (ELISA), detect bacterial antigens or antibodies, contributing to rapid and cost-effective diagnostics.

End-users in the Bacterial Disease Diagnostics Market primarily include hospitals and clinics, diagnostic laboratories, and research institutions. Hospitals and clinics play a crucial role in the frontline diagnosis and treatment of bacterial infections, relying on various diagnostic tools to guide patient management. Diagnostic laboratories, equipped with advanced technologies and trained personnel, contribute to comprehensive bacterial disease diagnostics. Research institutions drive innovation in diagnostic technologies, paving the way for the development of new and improved bacterial disease diagnostic methods.

Geographically, the market is expected to exhibit diverse trends. North America, Europe, and Asia-Pacific are anticipated to be major contributors to market growth. North America, with its well-established healthcare infrastructure and significant investments in research and development, is a key region for bacterial disease diagnostics. Europe, characterized by advanced healthcare systems and stringent regulatory standards, fosters the adoption of innovative diagnostic solutions. Asia-Pacific, including countries like China and India, witnesses a rising burden of bacterial diseases, creating opportunities for market expansion.

The forecast period is marked by ongoing advancements in bacterial disease diagnostic technologies, with a focus on improving speed, accuracy, and accessibility. Innovations include the development of rapid point-of-care testing devices for timely diagnostics, integration of artificial intelligence for data analysis, and the exploration of novel biomarkers for enhanced specificity. Additionally, the market is influenced by the growing trend towards multiplexed diagnostics, allowing simultaneous detection of multiple bacterial pathogens in a single test.

To Learn deeper into this report , View Sample PDF

Challenges in the Bacterial Disease Diagnostics Market include the need for standardization of diagnostic procedures, addressing the emergence of antibiotic-resistant bacteria, and ensuring accessibility to diagnostic tools in resource-limited settings. However, the market's growth prospects remain positive as the importance of early and accurate bacterial disease diagnosis gains prominence in global healthcare practices. The industry's evolution is characterized by a continuous quest for improved diagnostic accuracy, accessibility, and efficiency in addressing the complex challenges posed by bacterial infections.

For more information please contact.

[priyanshisingh]

Life Science Microscopy Devices Market - Future Growth Prospects for the Global Leaders

The latest market report published by Credence Research, Inc. “Global Life Science Microscopy Devices Market: Growth, Future Prospects, and Competitive Analysis, 2016 – 2028. The global life science microscopy devices market has witnessed steady growth in recent years and is expected to continue growing at a CAGR of 4.0% between 2023 and 2030. The market was valued at USD 1.3 billion in 2022 and is expected to reach USD 1.7 billion in 2030.

The market is primarily driven by developments in the micro components of medical sciences and healthcare, which have significantly impacted the demand for life science microscopy devices. The use of manual aids and devices for disease analysis and diagnosis in individuals with diverse medical backgrounds has increased, leading to a greater focus on life science microscopy equipment. Additionally, the utilization of microbiological particles for assessing patient health and well-being has brought attention to the field, further driving the demand for life science microscopy devices.

The global life science microscopy devices market offers significant growth opportunities, including the vast potential for expansion in the Asia Pacific region and the increasing adoption of microscopy for various research activities. Advancements in healthcare and medical science, such as drug development, imaging diagnostic techniques, nanoscience, and structural biology, contribute to the growing demand for technologically advanced microscopes.

However, the market also faces challenges, including high maintenance costs associated with certain microscope systems. Microscopes such as electron and scanning electron microscopes require steady voltage sources, electromagnetic coils, and cool water circulation, resulting in increased maintenance expenses and efforts.

Life Science Microscopy Devices Market Drivers refer to the key factors that propel the growth and development of the market for microscopy devices in life science applications. These drivers play a crucial role in shaping the demand for advanced imaging technologies, allowing scientists and researchers to gain deeper insights into biological processes at various levels of complexity. One significant driver is the increasing need for high-resolution imaging tools to study intricate cellular structures, molecular interactions, and dynamic processes within living organisms. As researchers strive to understand diseases better or develop new treatments, they require cutting-edge microscopy devices capable of capturing detailed images with exceptional clarity and precision.

Key players in the global life science microscopy devices market include Olympus Corporation, Thermo Fisher Scientific, Inc., Nikon Corporation, Carl Zeiss AG, Keyence Corporation, JEOL Ltd., Bruker, Hitachi High-Technologies Corporation, Leica Microsystems, and F. Hoffman-La Roche Ltd. These companies prioritize product innovation, expanding distribution channels, and strategic mergers and acquisitions to maintain a competitive position in the market.

Why to Buy This Report-

The report provides a qualitative as well as quantitative analysis of the global Life Science Microscopy Devices Market by segments, current trends, drivers, restraints, opportunities, challenges, and market dynamics with the historical period from 2016-2020, the base year- 2021, and the projection period 2022-2028.

The report includes information on the competitive landscape, such as how the market's top competitors operate at the global, regional, and country levels.

Major nations in each region with their import/export statistics

The global Life Science Microscopy Devices Market report also includes the analysis of the market at a global, regional, and country-level along with key market trends, major players analysis, market growth strategies, and key application areas.

Browse Full Report: https://www.credenceresearch.com/report/lifescience-microscopy-market

Visit: https://www.credenceresearch.com/

Related Report: https://www.credenceresearch.com/report/robotic-lung-biopsy-market

Related Report: https://www.credenceresearch.com/report/mosquito-repellent-wrisbands-market

Browse Our Blog: https://www.linkedin.com/pulse/asia-pacific-life-science-microscopy-devices-market-global-singh

[hx-technology]

Medical Device

Almost every medical equipment requires a fully assembled PCB in medical. Ultrasonic therapy equipment and blood pressure monitors are a few examples of standard medical equipment, and all of them count on PCBs to kick in. HX technology aims to provide multiple high-quality medical device products, including ultrasound machine PCB, endoscope PCB and glucometer PCB board.

 The trend of PCB Medical Industry

The medical field is not like it used to be. Advances in technology have revolutionized the industry. This change is even more evident in electronic diagnostic, research, and treatment systems and tools. Every day, several complex electronic devices and instruments are introduced to simplify various medical procedures. This growth has largely benefited the PCBA technology industry because, without PCB in medical, new inventions would not be impossible. To meet the ever-changing needs of medical device and diagnostic machine manufacturers, today's PCB manufacturers are manufacturing extremely simple parts into highly complex PCB in medical industry. Using specialized high-speed laminates, copper and aluminum substrates, ceramics, and coatings, PCB manufacturers can make these boards best suited for medical industry applications.

 Applications of PCB to Medical Industry

With the development of medical technology, more and more medical diagnostic, research and treatment have advanced, which need computer-aided. It means that medical devices and equipment must have a high level and high precise standard of the full form of PCBA in medical industry. Therefore, full form of PCB in medical has become more important in medical fields, which is the PCB meaning in medical.

 The rapid progress of medical science today is closely related to the development of the electronics industry. A lot of microbiological equipment and other instruments are individually based PCB, such as pH meters, heartbeat sensors, temperature measurements, ECG machines, EEG machines, MRI machines, X-rays, CT scans, blood pressure machines, blood glucose level measurement equipment, incubator, and some other medical equipment.

 Custom Medical PCB Assembly

Custom circuit board design in medical is the trend today. The medical industry has chosen the same approach when it comes to PCB. Customers can provide the correct specifications with the full form of PCB in medical for board size in X-direction, board size in Y-direction, total number of holes, minimum alignment and pitch size in inches, board material, number of layers, surface coating, etc. Therefore, the manufacturer will work according to the given specifications and deliver the right product for your application.

 Ultrasound PCB Application of Handheld Medical Equipment

With successive product improvements over the years and continued innovations throughout the market, handheld ultrasound devices are beginning to unlock their value. Among the early users of handheld, ultrasound are cardiologists, who use the device as an initial screening tool in the clinic, at the bedside during rounds, and in interventional units. Other users were more likely to be emergency physicians, especially emergency medical personnel, critical care staff in the intensive care unit, and military personnel. Subsequently, handheld ultrasound has gained some acceptance in procedural ultrasound (including vascular access and anesthesia). Specialists within the department are using handheld ultrasound for rapid examination and initial screening as an adjunct to more powerful onboard systems in hospital departments. PCBA suppliers are finding that an expanding customer base, coupled with affordable pricing, has led to global sales of handheld ultrasound PCBs.

 What is PCB Medical Meaning?

Printed circuit boards (PCB) have an important place in healthcare and medicine. As the industry continues to innovate to provide the best technology for patients and their caregivers. More and more research, treatment and diagnostic strategies are moving toward automation. As a result, more work involving PCB in medical is needed to improve medical devices in the industry. As the population ages, the full form of PCB in medical will continue to grow in importance in the medical industry. Currently, PCBs play an important role in medical imaging devices such as MRIs and cardiac monitoring devices such as pacemakers. Even temperature monitoring devices and responsive neurostimulators can be implemented with state-of-the-art PCB technology and professional PCB assembly.

 https://www.hx-technology.com/pcba-medical-device/

[globalmarketsresearchreports]

Global Microbiology Diagnostic Devices and Equipment Market Competitive Strategies and Forecasts to 2031

The Microbiology Diagnostic Devices and Equipment Global Market Report 2021-31 by The Business Research Company describes and explains the global microbiology diagnostic devices and equipment market and covers 2016 to 2021, termed the historic period, and 2022 to 2026, termed the forecast period, along with further forecasts for the period 2026-2031. The report evaluates the market across each region and for the major economies within each region.

The Microbiology Diagnostic Devices and Equipment Global Market Report 2022 covers microbiology diagnostic devices and equipment market drivers, microbiology diagnostic devices and equipment market trends, microbiology diagnostic devices and equipment market segments, microbiology diagnostic devices and equipment market growth rate, microbiology diagnostic devices and equipment market major players, and microbiology diagnostic devices and equipment market size.

View Complete Report:

The microbiology diagnostic devices and equipment market report provides in-depth analysis of the impact of COVID-19 on the global microbiology diagnostic devices and equipment industry along with revised market numbers due to the effects of the coronavirus and the expected microbiology diagnostic devices and equipment market growth numbers for 2022-2031.

The global microbiology diagnostic devices and equipment market size is expected to grow from $3.42 billion in 2021 to $3.98 billion in 2022 at a compound annual growth rate (CAGR) of 16.4%. The global microbiology diagnostic devices market share is expected to grow to $6.85 billion in 2026 at a CAGR of 14.6%.

Request Report Sample Now: https://www.thebusinessresearchcompany.com/sample.aspx?id=3408&type=smp

Microbiology Diagnostic Devices and Equipment Global Market Report 2022 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The chapter on the impact of COVID-19 gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market. The chapter also covers markets which have been positively affected by the pandemic.

TBRC’s report covers the microbiology diagnostic devices and equipment market segments- 1) By Type: Laboratory Instruments, Microbiology Analyzers

2) By End-User: Hospitals, Diagnostic Centers, Customer Lab Service Providers, Academic Institutes, Research Institutes

3) By Laboratory Instrument: Incubators, Gram Stainers, Bacterial Colony Counters, Petri Dish Fillers, Automated Culture Systems

4) By Microbiology Analyzer: Microbiology Diagnostics Instruments, Microscopes

5) By Reagent: Pathogen-Specific Kits, General Reagents

Table Of Contents

1. Executive Summary

2. Microbiology Diagnostic Devices And Equipment Market Characteristics

3. Microbiology Diagnostic Devices And Equipment Market Trends And Strategies

4. Impact Of COVID-19 On Microbiology Diagnostic Devices And Equipment

5. Microbiology Diagnostic Devices And Equipment Market Size And Growth

.

26. Africa Microbiology Diagnostic Devices And Equipment Market

27. Microbiology Diagnostic Devices And Equipment Market Competitive Landscape And Company Profiles

28. Key Mergers And Acquisitions In The Microbiology Diagnostic Devices And Equipment Market

29. Microbiology Diagnostic Devices And Equipment Market Future Outlook and Potential Analysis

30. Appendix

About The Business Research Company:  The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology. It has offices in the UK, the US and India and a network of trained researchers in 20+ countries globally.  

Contact Information:  The Business Research Company  Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Find us on

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany/

Blog: http://blog.tbrc.info/

[speedypeacething-blog]

In Vitro Diagnostics Market: Growth, Development and Forecast Report 2017 – 2027

Global In-Vitro Diagnostic Market, by Product & Services (Reagents & Kits, Instruments, Data Management Software, Services). By Technology (Immunoassay/Immunochemistry, Clinical Chemistry, Microbiology, Hematology, Coagulation and Hemostasis, Urinalysis, Other IVD Technologies). By End User (Hospitals, Laboratories, Point-Of-Care Testing, Patient Self-Testing, Academic Institutes, Other End Users). By Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Autoimmune Diseases, Nephrology, Drug Testing/Pharmacogenomics, HIV/Aids, & Other Applications) and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, & Africa) is expected to gain traction over the forecast period between 2019 and 2027.

For requesting a free sample to our latest study on Global In-Vitro Diagnostic Market, visit: https://meridianmarketconsultants.com/requst?rid=1694

In-Vitro Diagnostic Market Dynamics

Increase in the prevalence of autoimmune diseases and cancer is expected to drive the growth of the market in nearby future. According to the statistics published by the American Autoimmune Related Diseases Association, in 2019, around 50 million of the U.S. population is suffering from autoimmune disease. Autoimmune disease is considered in top 10 leading causes of death in women and girls up to the age of 64 years in the U.S.

Also, an increase in the government expenditure towards treatment of cancer is expected to be the one of the major factors that will drive the growth of market. For instance, according to the Insititute of Medicine report published in 2018, the U.S. is considered way behind in terms of research and development into immune system. In the year 2018, the National Institute of Health (NIH) contribute US$ 591 Mn on autoimmune disease research and development programs, which is very low in comparison to their spending on cancer research and development which is around US$ 6.1 billion.

Furthermore, an increase in the prevalence of cancer owing to the rapid growth in the consumption rate of alcohol and tobacco, sedentary lifestyle, and etc. is expected to act as a major factor that will drive the growth of the market around the globe. For instance, According to National Cancer Institute published data in 2018, it is estimated that 1,735,350 new cases of cancer will be diagnosed in the U.S. in the year 2018 and more than 600k people died due to the cancer. Also, on the basis of 2011-2015 cases, the incidence of cancer is 432.2/100,000 men and women. NCI also estimated that in 2017, a national expenditure for cancer care in the U.S.  was more than 147 billion and it is expected to increase in nearby future owing to an increase in the geriatric population and prevalence of cancer. The cost for the treatment will also increase due to the advancement in technology and new treatments likely to be adopted as standards of care.

Some of the other factors such as advancement in technology and increasing demand of point of care devices and an increase in the number of laboratory tests due to the increasing burden of many diseases and increasing research facility are likely to propel the growth of the market mainly in the developing economies.

The global In-Vitro diagnostic market in 2018 is accounted for more than US$ xx Bn and expected to reach a value of US$ XX Bn by 2027 with a significant CAGR of around 4.7 % over the forecast period of 2019-2027.

To know the latest insights, qualitative data, trends, quantitative data, and more related to Global In-Vitro Diagnostic Market, visit: https://meridianmarketconsultants.com/global-in-vitro-diagnostics-market

Global In-Vitro Diagnostic Market Regional Segmentation

On the basis region, the global in-vitro diagnostics market is segmented into six regions namely North America, Latin America, Asia Pacific, Europe, Middle East, and Africa. North America is accounted for the largest market share of more than 45% in the year 2018, and expected to maintain its dominance throughout the forecast period (2019-2027). It is due to the favorable government regulations and availability of funds from government mainly in the U.S. and also due to the presence of market-dominating players in the region.

Asia Pacific region is expected to grow at the highest annual growth rate in comparison to other regions during the forecast period, owing to the increasing incidence and prevalence in various countries like China and India.

Global In-Vitro Diagnostic Market Competitive Landscape

Some of the key participating players in the global In-Vitro Diagnostics market are Roche Diagnostics, Siemens Healthineers, Danaher Corporation, Abbott Laboratories, Thermo Fisher Scientific, Johnson & Johnson, Becton, Dickinson and Company, Bio-Rad Laboratories, Sysmex Corporation, bioMérieux, DiaSorin, Ortho Clinical Diagnostics, Agilent Technologies, QIAGEN, and among others.

Read Detailed News: https://meridianmarketconsultants.com/pressrelese/global-in-vitro-diagnostics-market

About Meridian Market Consultants:

Meridian Market Consultants (MMC) is committed to providing deep insights that serve as a creative tool for the client that enables it to perform confidently in the market. At MMC we adhere to the client's needs and regularly ponder to bring out more valuable and real outcomes for our customers. We are equipped with a strategically enhanced group of researchers and analysts that redefines and stabilizes the business polarity in different categorical dimensions of the market.

Contact Us:

Meridian Market Consultants (MMC)

13121, Louetta Road,

#440, Cypress, Texas 77429

United States

Tel: +1-(281)-619-8646

For Sales Queries: sales@meridianmarketconsultants.com

[itssashasharma]

Anatomic Pathology Market : Technological advancements in the field of Tissue Processors

According to the new market research report “Anatomic Pathology Market by Product & Service [Instruments (Tissue Processors, Microtome), Consumables (Antibodies), Histopathology], Application (Disease Diagnosis (Cancer (Gastrointestinal, Lung)], End User, Region – Global Forecasts to 2025″, published by MarketsandMarkets™, the Anatomic Pathology Market is projected to reach a value of USD 46.8 billion by 2025 from USD 33.3 billion in 2020, at a CAGR of 7.1% from 2020 to 2025.

Browse in-depth TOC on “Anatomic Pathology Market“

457 – Tables  34 – Figures   306 – Pages

Download PDF Brochure:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=137323145

The high incidence of cancer and other target diseases, availability of reimbursement, and the growing focus on personalized medicine are the major factors driving the growth of the anatomic pathology

The services segment accounted for the largest share of the market, by product & service, in 2019

Based on product & service, the Anatomic Pathology Market is segmented into services, consumables, and instruments. The services segment accounted for the largest share of the market in 2019. The large share of this segment can be attributed to the availability of reimbursements for diagnostic tests, rapid growth in the geriatric population, and the increasing incidence of cancer and other chronic diseases.

Hospital laboratories segment to register the highest growth rate during the forecast period

Based on end-users, the market is segmented into hospital laboratories, clinical laboratories, and other end users. In 2019, the hospital laboratories segment accounted for the largest market share and is expected to grow at the highest CAGR during the forecast period. The growth in this market can be attributed to the increasing number of patient visits to hospitals, a growing number of in-house diagnostic procedures performed in hospitals, rising awareness regarding early disease diagnosis, and the availability of reimbursements in developed markets for clinical tests performed in hospitals.

North America is the largest regional market for anatomic pathology

By region, the Anatomic Pathology Market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2019, North America accounted for the largest market share, followed by Europe. The rising prevalence of chronic diseases, increasing healthcare expenditure, the high-quality infrastructure for hospitals and clinical laboratories, and the presence of major market players in the region are driving the growth of the market in North America.

The prominent players operating in the Anatomic Pathology Market include F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), Hologic, Inc. (US), Agilent Technologies (US), Becton, Dickinson and Company (US), Sakura Finetek (Japan), Merck KGaA (Germany), Bio SB (US), Diapath S.p.A. (Italy), and BioGenex Laboratories (US).

Browse Adjacent Markets: Medical Devices Market Research Reports & Consulting

Browse Related Reports:

Anatomic Pathology Track and Trace Solutions Market

by Product (Software, Hardware (Printer & Labeling Systems), Consumables), Technology (Barcode, RFID), Application (Tissue Cassette, Slide Tracking), End User (Hospital Labs) – Global Forecast to 2023

https://www.marketsandmarkets.com/Market-Reports/anatomic-pathology-track-trace-solution-market-124099392.html

Slide Stainer Market by Product (Reagent, Equipment (Automated, Manual)), Technology (Hematoxylin & Eosin, Immunohistochemistry, In Situ Hybridization, Microbiology, Special Stains), End User (Hospital, Pharmaceutical, Academic) – Global Forecast to 2023

https://www.marketsandmarkets.com/Market-Reports/slide-stainer-market-134046412.html

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Aashish Mehra MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: +1-888-600-6441 Email: sales@marketsandmarkets.com Research Insight: https://www.marketsandmarkets.com/ResearchInsight/anatomic-pathology-market.asp Visit Our Website: https://www.marketsandmarkets.com Content Source: https://www.marketsandmarkets.com/PressReleases/anatomic-pathology.asp

[rahulg1122]

Laboratory Mixer Market worth $2.1 billion by 2025

The global laboratory mixers market size is projected to reach USD 2.1 billion by 2025 from USD 1.7 billion in 2020, at a CAGR of 3.7% during the forecast period growth in the laboratory mixers market is majorly driven by rising increasing research activity in the pharmaceutical and biotechnology industries and rising investments in R&D activities. 

Browse 89 market data Tables and 23 Figures spread through 152 Pages and in-depth TOC on "Laboratory Mixer Market"

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=163287347

The laboratory mixer market includes major Tier I and II suppliers like Thermo Fisher Scientific, Eppendorf, IKA Works, Cole-Parmer, and Avantor, Inc. (VWR). These suppliers have their manufacturing facilities spread across regions such as North America and Europe. COVID-19 has impacted their businesses as well. The laboratory mixers market is also faced a period of short-term negative growth, which can be attributed to factors such as a decline in the product demand from major end-users, limited operations in most of the industries, inadequate funding to research and academic institutes, temporary closure of major academic institutes, disrupted supply chain, and challenges in providing essential/postsales services due to lockdowns. These factors have led to reduced demand for laboratory mixers from end users. Research institutes are one of the major end users of laboratory instruments. As the pandemic resulted in the temporary closure of several research institutes across the globe, this end-user segment has been affected drastically over the last few months.

Wide use of orbital shakers in all basic research activities in laboratories, academic institutes, and pharmaceutical and biotechnology companies is expected to result in the segment occupying the majority of the laboratory mixers market share

The increasing focus on life science research is one of the major factors driving the demand for laboratory shakers. Most life science laboratories have multiple shakers owing to their wide applications in chemistry, biochemistry, molecular biology, analytical chemistry, microbiology, clinical diagnostics, and cell cultures. The most common application of shakers includes small-scale cultivation of cells in R&D and process development.

Digital Devices estimated to be the fastest-growing market

Digital devices are estimated to be the fastest-growing segment in the laboratory mixers market. The growth of this segment can be attributed use electronic sound transmission to operate, which makes it easier to connect these devices to a greater number of external devices. These devices are widely used by large pharmaceutical companies owing to the advantages they offer. Unlike analog devices, digital lab mixers have preprogramming functions.

North America is estimated to be the largest market due to the increasing demand for biopharmaceuticals and rising R&D expenditure by biopharmaceutical companies. These factors are supporting growth in the field of life science research, which, in turn, has contributed to the adoption of laboratory mixers.

Get a Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=163287347

Asia Pacific likely to emerge as the largest laboratory mixers market, globally

Asia Pacific is estimated to be the fastest-growing market for laboratory mixers during the forecast period. The Asia Pacific market is driven principally rising prevalence of diseases, increasing life science research, and investments by key market players in the growing APAC biomanufacturing sector, the Asia Pacific region is expected to provide significant growth opportunities for laboratory mixing equipment manufacturers.

Thermo Fisher Scientific (US), Eppendorf (Germany), IKA Works (Germany), Cole-Parmer (US), and Avantor, Inc. (VWR) (US) are the key players in the global laboratory mixers market.

[rupalic]

Food Safety Testing Market to Showcase Continued Growth in the Coming Years

The market for food safety testing is estimated to be USD 19.5 billion in 2021; it is projected to grow at a CAGR of 7.9% to reach USD 28.6 billion by 2026. The growth in the food safety testing market is attributed to the worldwide increase in the number of outbreaks of foodborne illnesses, implementation of stringent food safety regulations, and globalization of food supply. Lack of coordination between market stakeholders and improper enforcement of regulatory laws & supporting infrastructure in developing countries act as restraints for the food safety testing market. The challenges faced by the market include a lack of harmonization of food safety standards and high costs associated with the procurement of food safety testing equipment. COVID-19 Impact on the Global Food Safety Testing Market The COVID-19 pandemic is projected to have a significant impact on the food market, as it has highlighted the significance of safe, healthy, and nutritive eating. Food security, food safety, and food sustainability are recognized as strongly affected dimensions of food systems during the Covid-19 pandemic. The use of e-commerce to order deliveries of groceries and restaurant meals has risen sharply. Restaurant operators with established drive-thru and pick-up operations have fared much better than those competitors without. Sharp shifts in consumer behavior related to the food they consume were observed, with a higher preference for safety and quality. These have further propelled the manufacturers to assess the safety parameters of their food products to be able to sustain their product values in the market. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=365 Foodservice buyers worldwide have been affected tremendously by foodborne illnesses among consumers, and this has directed their attention toward obtaining certification of food safety assurance. Food manufacturers are willing to pay for testing and certification and have included this practice in their manufacturing cycles. Food companies, major retailers, and importers have been undertaking food safety testing to reduce the occurrence of foodborne diseases and legal conflicts as well. Food safety assurance has become important for food companies to comply with the global standards of food processing and labeling and meet the consumer demand for food safety. Food safety testing is conducted at critical levels of production and works as an essential step in certifying the quality and safety of food items served to customers. In the US, food recalls occur frequently. As a result, food production, food service, and food retail companies, together with government regulators, have increased efforts to ensure food safety, leading to the growth of the food safety testing market. Europe is estimated to be the largest market. The market in this region is primarily driven by growth in the German and UK markets. It is also driven by European food policies that have been extensively emphasized by the National Reference Laboratories (NRLs) and the European Reference Laboratories (EURLs) to maintain food standards and protect consumer health. The market is further fueled by the presence of major food safety testing companies such as SGS SA (Switzerland), Eurofins Scientific (Luxembourg), and Intertek Group plc (UK), which are continuously investing and collaborating for the development of better and faster testing technologies to aid conformity to various food safety regulations. The food safety testing market is dominated by few globally established players such as SGS SA (Switzerland), Eurofins Scientific (Luxembourg), Intertek Group plc (UK), Bureau Veritas (France), ALS Limited (Australia) and TÜV SÜD (Germany). These players have adopted growth strategies such as acquisition and agreements to increase their presence in the global market. SGS SA primarily offers inspection, verification, testing, certification, and quality assurance services. The company has nine business segments—consumer & retail; agriculture food & life; oil, gas & chemical; minerals; industrial; government & institution; transportation; certification & business enhancement; and environmental health & safety. It offers food safety testing through its agriculture food & life segment. The company operates through a network of more than 2,400 offices and laboratories across Europe, the Middle East, the Americas, Africa, and the Asia Pacific. With its strong presence, the company has established a strong market share and is identified as a strong player in the global food testing market. Its subsidiaries include SGS North America Inc. (US), SGS Germany GmbH (Germany), SGS India Private Ltd (India), and SGS United Kingdom Limited (UK). Major competitors of the company include Eurofins (Luxembourg), Intertek (UK), and Bureau Veritas (France), among others. Eurofins is an international group of laboratories that provide testing and support services to the pharmaceutical, food, environmental, agricultural, and consumer products industries and governments. The company capitalizes on a portfolio of 150,000 reliable analytical methods that enable it to offer services that characterize the safety, identity, purity, composition, authenticity, and origin of products & biological substances. It offers testing services through the following 13 divisions—food & feed testing, biopharma services, agroscience services, agro testing, clinical diagnostics, cosmetics testing, consumer product testing, forensic services, environmental testing, genomic services, medical devices, Eurofins technologies, and REACH services. It offers food testing services under its food & feed testing division. Food Safety Testing Market Dynamics Driver: Increase in global outbreaks of foodborne illnesses Incidences of foodborne illnesses occur primarily due to the consumption of food contaminated with a mycotoxin, pathogens, or the growth of yeasts and molds. The presence of pathogens such as Salmonella, Campylobacter, E. coli, and Listeria could compromise the microbiological safety of food, thereby resulting in foodborne illnesses. Furthermore, in the UK, around 1 million people suffer from foodborne illness, and nearly 20,000 people receive medical treatment for foodborne illnesses every year. Additionally, around 500 death cases have been reported due to food poisoning each year, costing close to USD 2.0 billion. Thus the market for food safety testing is steadily growing. Restraint: Complexity in testing techniques Existing technologies for food authenticity testing involve various difficulties in providing valid test results. Many chemical tests are unable to detect and quantify unknown adulterations. Other screening methods available in the laboratories are reported to have shortcomings in detecting and quantifying unknown adulterants. Thus many market players are investing into R&D inorder to develop more efficient and effective technologies. Opportunity: Technological advancements in the testing industry The focus on reducing lead time, sample utilization, cost of testing, and drawbacks associated with several technologies have resulted in technological innovation and the development of new technologies in spectrometry and chromatography. Wide-scale adoption of these technologies is an opportunity for medium- and small-scale laboratories to expand their service offerings and compete with large market players in the industry, as these technologies offer higher sensitivity, accuracy in results, reliability, multi-contaminant and non-targeted screening with low turnaround time, among other benefits. Request for Customization: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=365 Challenge: Lack of harmonization of food safety standards Neither ingredient suppliers nor retailers or food service companies are well served when duplicative standards and audits raise total costs for food certification without enhancing or ensuring the overall safety of food. Industrial experts have often suggested uniform and harmonized food safety standards to reduce the multiplicity of food laws for better efficiency. To eliminate the duplication and overlap among the multiple standards, government and private-sector stakeholders should work together to create transparent and uniform food certification standards.

[marketreports-world]

Blood Transfusion Diagnostics Market Research Report - Global Forecast Till 2027

Global Blood Transfusion Diagnostics Market Information, by product (Red Blood Cells, Platelets, Plasma, Albumin, Immunoglobulin Preparations, others) by Technology (Western Blot, ELISA, Nucleic Acid Amplification, Fluorescence assay, Rapid Test, others) by end user (Hospitals, Clinics, Blood banks, Laboratories) - Forecast till 2027

Ortho Clinical Diagnostics (U.S), Immucor (U.S), Beckman Coulter (U.S),  Grifols (Spain), Thermo Fisher Scientific, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), bioMérieux (France), Bio-Rad Laboratories, Inc. (U.S.), Siemens (Germany), Becton, Dickinson and Company (U.S.), Novartis AG (Switzerland), Beckman Coulter, Inc. (U.S.), Diagast (France), Abbott Diagnostics (U.S), BAG healthcare (Germany),  DiaSorin (Italy), Fujirebio (Belgium), Grifols (Spain), Quidel (U.S), Hologic/Gen-Probe (U.S), Biokit (Spain).are some of the prominent players at the forefront of competition in the global Blood Transfusion Diagnostics market and top seven players are profiled in MRFR Analysis.

Global Blood Transfusion Diagnostics Market   - Overview

Blood transfusion is an essential part of providing healthcare services to the patients. Blood and blood products like RBC’s, WBC’s, platelets and others are transfused from one person to another. This requires screening tests which are vital before conducting blood transfusion. Strict regulation governing the use and transfer of blood, increasing awareness regarding blood transfusion and automation of blood banks drive the growth of this market. Furthermore, increasing demand for diagnostic and treatment devices in developed and developing countries further influence the growth of the market. However, the growth of the market is restrained by various factors such as risk involved in transmission of infectious disease from one person to another without carrying out screening procedure.

Global Blood Transfusion Diagnostics Market   - Competitive Analysis

There is a significant increase in the number of the company offering blood transfusion diagnostics. Some major companies are trying to focus on new and advanced tests & products to gain the market. Whereas, some are has used the technique of acquisition and collaboration to gain the market.

Hoffmann-La Roche AG:

August, 2015: F. Hoffmann-La Roche AG acquired GeneWEAVE to strengthen offerings in microbiology diagnostics. Roche will pay GeneWEAVE shareholders USD 190 million upfront and up to USD 235 million in contingent product related milestones

February 2015 : F. Hoffmann-La Roche AG announced the collaboration with BioMed X for the development of Nanomaterial-Based Biosensors for Near-Patient Testing

September 2014: F. Hoffmann-La Roche AG launched Elecsys anti-Müllerian Hormone (AMH) fertility test for assessment of ovarian reserve for pregnancy

Abbott:

June, 2017: Alere shareholders approve amended merger with Abbott. This merger will further strengthen the global presence of the company.

August, 2016: Abbott announced the introduction of its new “Alinity”, a family of next generation systems across immunoassay, clinical chemistry, point of care, haematology, blood and plasma screening and molecular diagnostics.

April, 2016: The company received FDA approval for its companion diagnostics “Vysis CLL FISH probe kit” in Leukemia. The kit is used to detect the 17p deletion in chronic lymphocytic leukemia patients, the target population of a new drug from AbbVie.

April, 2016: Abbott received FDA approval for its companion diagnostics “Vysis CLL FISH probe kit” in Leukemia. The kit is used to detect the 17p deletion in chronic lymphocytic leukemia patients, the target population of a new drug from AbbVie.

Bio-Rad Laboratories, Inc.:

July 2017: Bio-Rad Laboratories, Inc., a global provider of life science research and clinical diagnostic products launched Amplichek I quality control for the testing of infectious diseases.

Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/1126

Global Blood Transfusion Diagnostics Market   - Regional Analysis

Globally, America’s account for the largest market share in blood transfusion diagnostics market consists of two regions namely North America and South America. Increasing in number of blood banks, adoption of automation in blood banks, awareness programs in school & medical institutes and demand of safe and reliable technology for blood transfusion drive this market in North America. Increasing adoption of Nucleic Acid Amplification for diagnosis of blood and blood products also contribute to the growth of this market in North America. United States is the biggest market place worldwide contributing 46% of total blood transfusion diagnostics market. Ortho-Clinical Diagnostic is the largest transfusion diagnostic equipment and solution provider with estimated market share of 7 to 8%. Medical institutes conduct lecture and conference on safe blood transfusion for medical students and also for patients. Europe blood transfusion diagnostics market has observed stable growth owing to increasing demand for advanced diagnostic products. Asia-Pacific is fastest growing market region for this market due to presence of huge patient pool, and huge opportunity for the market growth. The Middle East and Africa holds the least share in the market due to lack of awareness among the people and limited development of medical sector.

Table Of Contents

1. Report Prologue

2. Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

2.3 Market Structure

2.4. Market Segmentation

3. Research Methodology

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

3.5 Forecast Model

4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Threats

4.5 Macroeconomic Indicators

5. Market Factor Analysis

5.1 Value Chain Analysis

5.2 Porters Five Forces

5.3 Demand & Supply: Gap Analysis

5.4 Pricing Analysis

5.5 Investment Opportunity Analysis

5.6 Merger And Acquisition Landscape

5.7 Up-Coming Trends In Blood Transfusion Diagnostics Market

5.7.1 Market Trends

5.7.2 Technological Trends

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/blood-transfusion-diagnostics-market-1126

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Related Report:

Global Acute Pancreatitis Market Research Report—Forecast till 2025

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

[market-research-future]

Blood Transfusion Diagnostics Market Share, Insights, Segmentation and Investment | Forecast to 2027

Ortho Clinical Diagnostics (U.S), Immucor (U.S), Beckman Coulter (U.S),  Grifols (Spain), Thermo Fisher Scientific, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), bioMérieux (France), Bio-Rad Laboratories, Inc. (U.S.), Siemens (Germany), Becton, Dickinson and Company (U.S.), Novartis AG (Switzerland), Beckman Coulter, Inc. (U.S.), Diagast (France), Abbott Diagnostics (U.S), BAG healthcare (Germany),  DiaSorin (Italy), Fujirebio (Belgium), Grifols (Spain), Quidel (U.S), Hologic/Gen-Probe (U.S), Biokit (Spain).are some of the prominent players at the forefront of competition in the global Blood Transfusion Diagnostics market and top seven players are profiled in MRFR Analysis.

Global Blood Transfusion Diagnostics Market   - Overview

Blood transfusion is an essential part of providing healthcare services to the patients. Blood and blood products like RBC’s, WBC’s, platelets and others are transfused from one person to another. This requires screening tests which are vital before conducting blood transfusion. Strict regulation governing the use and transfer of blood, increasing awareness regarding blood transfusion and automation of blood banks drive the growth of this market. Furthermore, increasing demand for diagnostic and treatment devices in developed and developing countries further influence the growth of the market. However, the growth of the market is restrained by various factors such as risk involved in transmission of infectious disease from one person to another without carrying out screening procedure.

Global Blood Transfusion Diagnostics Market   - Competitive Analysis

There is a significant increase in the number of the company offering blood transfusion diagnostics. Some major companies are trying to focus on new and advanced tests & products to gain the market. Whereas, some are has used the technique of acquisition and collaboration to gain the market.

Hoffmann-La Roche AG:

August, 2015: F. Hoffmann-La Roche AG acquired GeneWEAVE to strengthen offerings in microbiology diagnostics. Roche will pay GeneWEAVE shareholders USD 190 million upfront and up to USD 235 million in contingent product related milestones

February 2015 : F. Hoffmann-La Roche AG announced the collaboration with BioMed X for the development of Nanomaterial-Based Biosensors for Near-Patient Testing

September 2014: F. Hoffmann-La Roche AG launched Elecsys anti-Müllerian Hormone (AMH) fertility test for assessment of ovarian reserve for pregnancy

Abbott:

June, 2017: Alere shareholders approve amended merger with Abbott. This merger will further strengthen the global presence of the company.

August, 2016: Abbott announced the introduction of its new “Alinity”, a family of next generation systems across immunoassay, clinical chemistry, point of care, haematology, blood and plasma screening and molecular diagnostics.

April, 2016: The company received FDA approval for its companion diagnostics “Vysis CLL FISH probe kit” in Leukemia. The kit is used to detect the 17p deletion in chronic lymphocytic leukemia patients, the target population of a new drug from AbbVie.

April, 2016: Abbott received FDA approval for its companion diagnostics “Vysis CLL FISH probe kit” in Leukemia. The kit is used to detect the 17p deletion in chronic lymphocytic leukemia patients, the target population of a new drug from AbbVie.

Bio-Rad Laboratories, Inc.:

July 2017: Bio-Rad Laboratories, Inc., a global provider of life science research and clinical diagnostic products launched Amplichek I quality control for the testing of infectious diseases.

Report Details @ https://www.marketresearchfuture.com/reports/blood-transfusion-diagnostics-market-1126

Global Blood Transfusion Diagnostics Market   - Regional Analysis

Globally, Americas account for the largest market share in blood transfusion diagnostics market consists of two regions namely North America and South America. Increasing in number of blood banks, adoption of automation in blood banks, awareness programs in school & medical institutes and demand of safe and reliable technology for blood transfusion drive this market in North America. Increasing adoption of Nucleic Acid Amplification for diagnosis of blood and blood products also contribute to the growth of this market in North America. United States is the biggest market place worldwide contributing 46% of total blood transfusion diagnostics market. Ortho-Clinical Diagnostic is the largest transfusion diagnostic equipment and solution provider with estimated market share of 7 to 8%. Medical institutes conduct lecture and conference on safe blood transfusion for medical students and also for patients. Europe blood transfusion diagnostics market has observed stable growth owing to increasing demand for advanced diagnostic products. Asia-Pacific is fastest growing market region for this market due to presence of huge patient pool, and huge opportunity for the market growth. The Middle East and Africa holds the least share in the market due to lack of awareness among the people and limited development of medical sector.

Browse Related Reports at:

Clinical Perinatal Software Market Size, Growth, Trends, Forecast to 2027 | MRFR

Spectral Computed Tomography (CT) Market Size, Share and Growth | Forecast to 2027

Osteosarcoma Market Size, Share, Treatment and Trends | Global Industry Forecast 2027

[hx-technology]

Medical Device

https://www.hx-technology.com/pcba-medical-device/

Almost every medical equipment requires a fully assembled medical circuit board. Ultrasonic therapy equipment and blood pressure monitors are a few examples of standard medical equipment, and all of them count on PCBs to kick in. HX technology aims to provide multiple high-quality medical device products, including ultrasound machine PCB, endoscope PCB and glucometer PCB board.

 The trend of PCB Medical Industry

The medical field is not like it used to be. Advances in technology have revolutionized the industry. This change is even more evident in electronic diagnostic, research, and treatment systems and tools. Every day, several complex electronic devices and instruments are introduced to simplify various medical procedures. This growth has largely benefited the PCB industry because, without PCB, new inventions would not be impossible. To meet the ever-changing needs of medical device and diagnostic machine manufacturers, today's PCB manufacturers are manufacturing extremely simple parts into highly complex printed circuit boards in PCB medical industry. Using specialized high-speed laminates, copper and aluminum substrates, ceramics, and coatings, PCB manufacturers can make these boards best suited for medical industry applications.

 Applications of PCB for Medical Industry

With the development of medical technology, more and more medical diagnostic, research and treatment have advanced, which need computer-aided. It means that medical devices and equipment must have a high level and high precise standard of medical PCB. Therefore, medical PCBA has become more important in medical fields, which is the PCB meaning in medical.

 The rapid progress of medical science today is closely related to the development of the electronics industry. A lot of microbiological equipment and other instruments are individually based PCB, such as pH meter, heartbeat sensor, temperature measurement, ECG machine, EEG machine, MRI machine, X-ray, CT scan, blood pressure machine, blood glucose level measurement equipment, incubator, and some other medical equipment.

 Custom Medical PCB Assembly

Customization of medical PCB assembly is the trend today. The medical industry has chosen the same approach when it comes to PCB. Customers can provide the correct specifications with the full form of PCB in medical for board size in X-direction, board size in Y-direction, total number of holes, minimum alignment and pitch size in inches, board material, number of layers, surface coating, etc. Therefore, the manufacturer will work according to the given specifications and deliver the right product for your application.

 Ultrasound PCB Application of Handheld Medical Equipment

With successive product improvements over the years, and continued innovations throughout the market, handheld ultrasound devices are beginning to unlock their value. Among the early users of handheld ultrasound are cardiologists, who use the device as an initial screening tool in the clinic, at the bedside during rounds, and in interventional units. Other users were more likely to be emergency physicians, especially emergency medical personnel, critical care staff in the intensive care unit, and military personnel. Subsequently, handheld ultrasound has gained some acceptance in procedural ultrasound (including vascular access and anesthesia). Specialists within the department are using handheld ultrasound for rapid examination and initial screening as an adjunct to more powerful on-board systems in hospital departments. Circuit board manufacturers are finding that an expanding customer base, coupled with affordable pricing, has led to global sales of handheld ultrasound PCB.

 What is PCB Medical Meaning?

Printed circuit boards (PCB) have an important place in healthcare and medicine. As the industry continues to innovate to provide the best technology for patients and their caregivers. More and more research, treatment and diagnostic strategies are moving toward automation. As a result, more work involving PCB assembly is needed to improve medical devices in the industry. As the population ages, PCB assembly will continue to grow in importance in the medical industry. Currently, PCBs play an important role in medical imaging devices such as MRIs and cardiac monitoring devices such as pacemakers. Even temperature monitoring devices and responsive neurostimulators can be implemented with state-of-the-art PCB technology and components.

[itssashasharma]

Laboratory Freezers Market worth USD 5.7 billion : Rollout of COVID-19 vaccines requiring freezer storage

According to the new market research report “Laboratory Freezers Market by Product(Cryopreservation, Plasma Freezer, ExplosionProof Freezer, Enzyme Freezer, Ultra-Low Freezer, Blood Bank Refrigerator, Pharmacy Refrigerator, Chromatography Refrigerator), End User(Hospitals) – Global Forecast to 2026″, published by MarketsandMarkets™, the Laboratory Freezers Market is projected to reach USD 5.7 billion by 2026 from USD 4.7 billion in 2022, at a CAGR of 4.9%.

Browse in-depth TOC on “Laboratory Freezers Market” 274 – Tables 52 – Figures 291 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=196600540

The Growth in the market is driven by the increasing demand for blood and blood components for transfusion and for support in cancer therapy.

The laboratory freezers market has shown a significant rise in demand in 2020 and 2021 due to the utility of these products for appropriate temperature-controlled storage of COVID-19 vaccines. This demand is expected to decline after 2021 and remain steady from 2022, fueled by pre-pandemic growth drivers. However, the market during 2022–2026 may show growth if booster doses of COVID-19 vaccines are made mandatory during the forecast period.

The market growth is restrained by the growing use of refurbished laboratory freezers. In this report, the global lab freezers market is segmented by product, end user, and region.

Based on products, the laboratory freezers market is segmented into freezers, refrigerators, and cryopreservation systems. In 2020, the freezers segment accounted for the largest share in the lab freezers market.

The freezers segment holds the highest market share, by product, in the laboratory freezers market, in the forecast period.

In 2020, the freezers segment accounted for the largest share of the lab freezers market. The large share of this segment can be attributed to their utility in pharmaceutical and biotechnology companies and academic and research institutes to support vaccine development and in medical laboratories and hospitals for storing test samples.

In the freezers segment, the ultra-low-temperature freezers segment is expected to grow at the highest CAGR in the forecast period.

The ultra-low-temperature freezers segment is expected to grow at the highest CAGR in the forecast period. The large share of this segment can be attributed to their utility in pharmaceutical and biotechnology companies and academic and research institutes to support vaccine development and in medical laboratories and hospitals for storing test samples.

The laboratory refrigerators segment holds the highest share in the refrigerators segment

Based on type, the laboratory freezers market is segmented into blood bank refrigerators, chromatography refrigerators, explosion-proof refrigerators, flammable material refrigerators, laboratory refrigerators, and pharmacy refrigerators. In 2020, the laboratory refrigerators segment accounted for the largest shatories, hospitals, and clinics.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=196600540

Latin America is expected to grow at the highest CAGR, by region, in the forecast period

The laboratory freezers market is segmented into North America, Europe, Asia Pacific, Latin America and Mare of the refrigerators segment. In 2020 and 2021, this segment shows high growth due to the extensive use of laboratory refrigerators in the short-term storage of samples for COVID-19 testing in medical laboriddle East & Africa. APAC to grow at the highest CAGR in the lab freezers market during the forecast period. Latin America is one of the fastest-growing markets for laboratory freezers owing to growing investments from global pharmaceutical manufacturers in Latin America and the availability of government funding for R&D activities as well as efforts to modernize the existing healthcare system.

Prominent players in the laboratory freezers market include Eppendorf AG (Germany), Haier Biomedical (China), Thermo Fisher Scientific, Inc. (US), Helmer Scientific (US), PHC Holdings Corporation (Japan), Liebherr (Switzerland), Middleby Corporation (Follett Products, LLC), Felix Storch, Inc. (US), BioLife Solutions, Inc. (Stirling Ultracold) (US), Blue Star Limited (India), B Medical Systems (Luxembourg), Philipp Kirsch GmbH (Germany), Avantor, Inc. (US), Standex International Corporation (US), Vestfrost Solutions A/S (Denmark), Changhong Meiling Co. Ltd. (China), EVERmed S.R.L. (Italy), ARCTIKO A/S (Denmark), Glen Dimplex Medical Appliances (LEC Medical) (Ireland), So-Low Environmental Equipment Co. Ltd. (US), KW Apparecchi Scientifici SRL (Italy), Jeio Tech (Republic of Korea), Refrigerated Solutions Group (US), Stericox India Private Limited (India), Thalheimer Kühlung (Germany), and Antylia Scientific (US).

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=196600540

Browse Adjacent Markets: Medical Devices Market Research Reports & Consulting

Browse Related Reports:

Lab Automation Market by Product (Robotic Arm, Microplate Readers, Workstation, LIMS, ELN), Application (Drug Discovery, Diagnostics, Genomics, Proteomics, Microbiology), End-User (Pharma, Diagnolab, Forensics, Environmental) – Global Forecast to 2025 https://www.marketsandmarkets.com/Market-Reports/lab-automation-market-1158.html

Laboratory Equipment Services Market by Type (Repair & Maintenance, Calibration, Validation), Contract (Standard, Custom), Equipment (Analytical, Equipment, General, Support), Service Provider (OEM), and End User (Pharmaceutical) – Global Forecast to 2024

https://www.marketsandmarkets.com/Market-Reports/laboratory-equipment-service-market-171213101.html

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact: Mr. Aashish Mehra MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: +1-888-600-6441 Email: sales@marketsandmarkets.com Research Insight: https://www.marketsandmarkets.com/ResearchInsight/laboratory-freezer-market.asp Visit Our Web Site: https://www.marketsandmarkets.com Content Source:  https://www.marketsandmarkets.com/PressReleases/laboratory-freezer.asp